相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Management of pre-, peri-, and post-menopausal abnormal uterine bleeding: When to perform endometrial sampling?
Efthymia Papakonstantinou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia et al.
CHINESE MEDICAL JOURNAL (2022)
Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy
Antonio Raffone et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)
Endometrial cancer
Emma J. Crosbie et al.
LANCET (2022)
Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples
Tatiana Cuesta-Guardiola et al.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Abnormalities of early folliculogenesis and serum anti-Mullerian hormone in chinese patients with polycystic ovary syndrome
Juan Du et al.
JOURNAL OF OVARIAN RESEARCH (2021)
Endometrial cancer: A systematic review of HE4, REM and REM-B
Manon Degez et al.
CLINICA CHIMICA ACTA (2021)
Anti-Mullerian Hormone in Female Reproduction
Nathalie di Clemente et al.
ENDOCRINE REVIEWS (2021)
Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
Aneta Cymbaluk-Ploska et al.
DIAGNOSTICS (2021)
Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding
Stephanie R. DeJong et al.
CANCER MEDICINE (2021)
HE4 as a Biomarker for Endometrial Cancer
Roya Behrouzi et al.
CANCERS (2021)
Rate of premalignant and malignant endometrial lesion in low-risk premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
Sangam Jha et al.
OBSTETRICS & GYNECOLOGY SCIENCE (2021)
Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study
Casper Reijnen et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis
Michelle T. Doherty et al.
PLOS ONE (2020)
Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer
Yaowei Li et al.
BMC GENETICS (2020)
A Clinical Comparative Study of Two Different Endometrial Cell Samplers for Evaluation of Endometrial Lesions by Cytopathological Diagnosis
Shulan Lv et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women
Jacopo Troisi et al.
JAMA NETWORK OPEN (2020)
Endometrial Cancer
Karen H. Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study
Xiaoting Ling et al.
MEDICAL SCIENCE MONITOR (2020)
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
Kelechi Njoku et al.
FRONTIERS IN ONCOLOGY (2020)
Preoperative markers for the prediction of high-risk features in endometrial cancer
Pinyada Panyavaranant et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)
A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge
Lili Ge et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
AMH and Its Clinical Implications
Laxmi Shrikhande et al.
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2020)
New perspectives on screening and early detection of endometrial cancer
Laura Costas et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
CLINICAL ENDOCRINOLOGY (2018)
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Karin Abbink et al.
TUMOR BIOLOGY (2018)
Premenopausal abnormal uterine bleeding and risk of endometrial cancer
Me Pennant et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Daria Lizneva et al.
FERTILITY AND STERILITY (2016)
Cancer biomarker detection: recent achievements and challenges
Li Wu et al.
CHEMICAL SOCIETY REVIEWS (2015)
Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays
Scott M. Nelson et al.
FERTILITY AND STERILITY (2015)
Performance of the two new fully automated anti-Mullerian hormone immunoassays compared with the clinical standard assay
Josef van Helden et al.
HUMAN REPRODUCTION (2015)
Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay
Lina Zhou et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Prediction of Regression and Relapse of Endometrial Hyperplasia With Conservative Therapy
Ioannis D. Gallos et al.
OBSTETRICS AND GYNECOLOGY (2013)
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
C. Villarroel et al.
HUMAN REPRODUCTION (2011)
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2011)
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
Ian Jacobs et al.
LANCET ONCOLOGY (2011)
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Jayawant N. Mandrekar
JOURNAL OF THORACIC ONCOLOGY (2010)
Body Mass Index and Risk of Ovarian Cancer
Michael F. Leitzmann et al.
CANCER (2009)
Factors affecting adequacy of Pipelle and Tao Brush endometrial sampling
A. R. W. Williams et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women
A. Ben-Arie et al.
EJSO (2008)
Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
C Weenen et al.
MOLECULAR HUMAN REPRODUCTION (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)